Connect with us

Technology

Power Wins DPHARM Idol Disrupt 2024 by Connecting Patients and Sites to Clinical Trials with a Simplified Platform

Published

1 day ago

on

The Conference Forum is pleased to announce that Power is the winner of DPHARM Idol Disrupt at the 14th annual DPHARM: Disruptive Innovations to Advance Clinical Research 2024 event.

PHILADELPHIA, Sept. 18, 2024 /PRNewswire-PRWeb/ — The Conference Forum is pleased to announce that Power is the winner of DPHARM Idol Disrupt at the 14th annual DPHARM: Disruptive Innovations to Advance Clinical Research 2024 event.

“AI-driven curation of patient-friendly lay language is a game-changer. Power has unlocked access to clinical trials in a low-overhead, AI-forward way, and is helping patients not only find trials, but learn more about them and connect directly to a clinical research site,” Nicole Sheetz, Gilead.

Power, represented by Brandon Li, Co-Founder, is building patient-friendly access to clinical trials, and is simplifying recruitment with a novel AI approach that delivers qualified referrals that match protocol criteria and supports the entire process through to enrollment.

“Roughly 86% of all clinical trials are delayed due to an inability to recruit enough patients. By making it dead simple to discover and evaluate novel therapies, we’re hoping to offer patients a source of hope while reducing the time it takes for new breakthrough drugs to reach approval,” said Mr Li.

In front of 12 judges representing R&D executives, patient advocates, and life science investors, Power had six minutes to present how their platform helped patients navigate clinical trial options, scanned patient-uploaded medical documents for inclusion/exclusion criteria to match patients to potential trials, and let patients browse nearby sites. Mr Li also told the DPHARM audience that physicians and care providers had begun using the platform as well.

“AI-driven curation of patient-friendly lay language is a game-changer. Power has unlocked access to clinical trials in a low-overhead, AI-forward way, and is helping patients not only find trials, but learn more about them and connect directly to a clinical research site,” said Nicole Sheetz, PharmD, Senior Director, Design & Innovation, Global Development, Gilead.

“Patients are always looking for information, and it’s hard to make a decision in a pressurized environment. Power makes it clean, simple and user-friendly. When patients understand and retain information, especially from underrepresented communities, they are more likely to engage and exercise their options,” said Karen Peterson, Founder and Chief Patient Advocate, Karen’s Club.

Power had strong competition from the other DPHARM Idol Disrupt finalist contenders, which included:

Beaconcure, represented by Ilan Carmeli, COO and Co-Founder, and Sean Wall, SVP, CommercialThoughtSphere, represented by Avi Kulkarni, PhD, CEOInspire, represented by Brett Kleger, CEOProofPilot, represented by Chris Venezia, CEOInSilicoTrials, represented by Mario Torchia, Chief Operating Officer, and MaryAnne Rizk, Advisor

The DPHARM Idol Disrupt 2024 judges were:

Mohammed Ali, R&D Head of Business Performance & Analytics, CMO Office, AstellasMary Brantner, Senior Director, Clinical Program Optimization and Innovation, Insmed IncorporatedEsther Dyson, Founder, WellvilleBill Illis, Head, Technology and Collaboration, NovartisHassan Kadhim, Business Engagement Lead for Clinical Operations and Development, Vertex PharmaceuticalsKaren Peterson, Founder and Chief Patient Advocate, Karen’s ClubDoug Schantz, SVP, Clinical Operations, Asklepios BioPharmaceutical, Inc.Nicole Sheetz, PharmD, Senior Director, Design & Innovation, Global Development, GileadLauren Sunshine, Director, Product Management, Digital Health, BMSMark Travers, PhD, MBA, VP, Head Global Clinical Trial Operations, Regions and Regional Operations, Merck & Co., Inc.Donna Usiskin, Chief Strategy Officer, New Enterprise VenturesHenry Wei, MD, Head of Development Innovation, Regeneron Pharmaceuticals Inc

The DPHARM Idol Disrupt 2024 moderator was:

Sheryl Jacobs, VP, Global Development Operations, Amgen

For more information, please contact service@tcfllc.org or visit theconferenceforum.org.

About DPHARM:
DPHARM® offers an unparalleled opportunity to hear senior clinical operation executives and innovative thought leaders report on the latest innovations to Advance clinical trials. The concept of DPHARM was founded by Pfizer and Janssen, who continue to play a key role on the steering committee to deliver a highly relevant and engaging program.

About The Conference Forum:
The Conference Forum is a life science industry research firm that brings key people together to share and exchange ideas and information on how to get therapeutics to patients faster. We continue to examine and challenge the complex ecosystem of drug development and delivery, bringing ideas together from a variety of sources to help advance clinical research with common, patient-centered goals. Each of our key research areas – Clinical Trial Innovation, Patients as Partners, R&D Leadership, Immuno-Oncology, Drug Delivery and Clinical Research as a Care Option – has a dedicated conference, quarterly newsletter and podcasts.

Media Contact

Danny McCarthy, DPHARM, 646-350-2580, service@tcfllc.org, https://dpharmconference.com/

View original content:https://www.prweb.com/releases/power-wins-dpharm-idol-disrupt-2024-by-connecting-patients-and-sites-to-clinical-trials-with-a-simplified-platform-302251881.html

SOURCE DPHARM

Related Topics:
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

Dana-Farber Cancer Institute Partners with Clinical.ly to Enhance Regulatory Operations with eReg Solutions

Published

45 mins ago

on

September 19, 2024

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — The Dana-Farber Cancer Institute, a world leader in cancer treatment and research, chose Clinical.ly’s (www.clinical.ly) Research Suite™ to streamline regulatory operations, marking a significant step toward more efficient and compliant clinical trial management. Dana-Farber joins a growing number of research organizations that leverage Clinical.ly’s innovative solutions to streamline clinical trial processes. Clinical.ly’s eReg platform offers a comprehensive, paperless solution that centralizes regulatory workflows, ensuring compliance and transparency across clinical trials.

“We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO.

This partnership continues Clinical.ly’s success in providing best-in-class enterprise tools for conducting clinical research. “We are thrilled to support Dana-Farber’s clinical research operations,” said Henry Kravchenko, Clinical.ly’s CEO. “Our eReg platform and wider set of features in Clinical.ly Research Suite™ will empower that renowned organization, and we all look forward to supporting their teams.”

About Clinical.ly Research Suite™ 

Clinical.ly Research Suite™ is a comprehensive solution that eliminates traditional, paper-based processes. By automating and centralizing essential workflows in the Clinical.ly Research Suite™, organizations achieve huge efficiency improvements, greater trial oversight, document management, and regulatory compliance. The Clinical.ly Research Suite™ includes:

eReg: A best-in-class electronic regulatory bindereSource: An intuitive & feature-rich, paperless data capture solution that streamlines data collection from trial participantseConsent: A fully digital solution for capturing informed consent, improving participant engagement and site complianceClinicallySign: 21 CFR Part 11 compliant eSignature functionalityClinicallyPay: A secure and instantaneous participant stipend payment and reimbursement solution

About Dana-Farber Cancer Institute

Founded in 1947, Dana-Farber Cancer Institute is committed to providing adults and children with the best treatment available today while developing tomorrow’s cures through cutting-edge research. Based in Boston, Dana-Farber is a teaching affiliate of Harvard Medical School and ranks consistently as one of the top cancer hospitals in the world.

About Clinical.ly

Clinical.ly provides differentiated, cloud-native technology solutions to the clinical research industry, enabling research organizations to conduct studies with greater efficiency and ease. Clinical.ly is dedicated to developing technology that eliminates tedious manual labor, allowing clinical research professionals to focus on patient care.

View original content to download multimedia:https://www.prnewswire.com/news-releases/dana-farber-cancer-institute-partners-with-clinically-to-enhance-regulatory-operations-with-ereg-solutions-302253690.html

SOURCE Clinical.ly

Continue Reading

Technology

Fall Into Creativity with the Monport Laser Fall Sale

Published

45 mins ago

on

September 19, 2024

By

NEW YORK, Sept. 19, 2024 /PRNewswire/ — Experience laser innovation this Fall with Monport Laser, an industry frontrunner in laser engraving and cutting technology, with an exclusive Fall Sale offering incredible discounts and free accessories on a wide range of high-performance laser engraving machines. From September 19th to September 30th, customers can take advantage of this limited-time opportunity to elevate their laser engraving businesses with cutting-edge laser innovation at unbeatable prices.

Monport Laser has been dedicated to providing innovative and reliable laser machines that empower businesses and individuals to achieve their goals. With a focus on quality, precision, and customer satisfaction, Monport Laser has established itself as a trusted leader in the industry. Their commitment to excellence is evident in every laser they produce, ensuring exceptional performance, reliability, and value.

Embrace the Power of CO2 Laser Technology with Exclusive Offers

Monport Laser will offer two free accessories with selected CO2 laser machines during the Monport Fall sale. These versatile lasers are ideal for various applications, including engraving, cutting, and marking wood, acrylic, leather, and more. By taking advantage of this Fall sale, laser engraving businesses can enhance their productivity and expand their creative possibilities.

Experience Unmatched Value with Fiber Laser Discounts

Monport Laser offers substantial discounts of up to $4200 and 3 free accessories on selected models for those seeking the precision and speed of fiber laser technology. Fiber lasers are renowned for their ability to process metals with exceptional efficiency and accuracy, making them indispensable for metal fabrication, manufacturing, and jewelry production. Additionally, customers purchasing fiber lasers during the Fall sale will receive three free accessories, further sweetening the deal.

Elevate Your Desktop Laser Experience with a Free Water Chiller

Monport Laser is committed to providing comprehensive solutions for businesses of all sizes. As part of the Fall sale, customers who purchase the 40W Desktop laser will receive a Free Water Chiller Cw3000. This essential accessory ensures optimal cooling and performance, prolonging the lifespan of the laser and guaranteeing consistent results.

Discover Additional Savings on a Wide Range of Accessories

Monport Laser offers an additional 20% discount on selected accessories to complete your laser setup. From lenses and nozzles to rotary tables and smoke extraction systems, customers can find everything they need to maximize the potential of their laser machines.

Unleash Your Creativity and Productivity

Monport Laser’s Fall sale is the perfect opportunity to invest in laser technology that empowers your business or fuels your creative passions. With exceptional discounts and free accessories, you can acquire the ideal laser solution to meet your needs and budget.

Whether you’re an entrepreneur, artist, or manufacturer, Monport Laser’s advanced laser machines offer unparalleled precision, versatility, and reliability. Take advantage of this limited-time Fall sale and unlock your projects’ full potential for laser innovation.

About Monport Laser

Monport Laser is a global leader in designing, manufacturing, and distributing high-quality laser machines and accessories. With a commitment to innovation and customer satisfaction, Monport Laser provides cutting-edge solutions for various industries, including manufacturing, engraving, marking, and more.

For more information, visit monportlaser.com and follow them on social media for the latest updates.

Website: https://www.monportlaser.com/

 

 

 

View original content:https://www.prnewswire.com/news-releases/fall-into-creativity-with-the-monport-laser-fall-sale-302253699.html

SOURCE Monport Laser

Continue Reading

Technology

MEDIA ADVISORY – Minister Wilkinson to Make a Critical Minerals Infrastructure Announcement

Published

45 mins ago

on

September 19, 2024

By

VANCOUVER, BC, Sept. 19, 2024 /CNW/ – The Honourable Jonathan Wilkinson, Minister of Energy and Natural Resources, and Ranj Pillai, the Premier of Yukon, will make a funding announcement in support of critical minerals infrastructure projects. A media availability will follow.

Date: September 20, 2024

Time: 10:30 a.m. PT

All accredited media are asked to pre-register by emailing media@nrcan-rncan.gc.ca. A dial-in line is available for media and will be provided upon registration.

Follow us on LinkedIn

SOURCE Natural Resources Canada

Continue Reading

Trending